Neuroscience Education Institute

Recent papers from Neuroscience Education Institute

1. Healthcare Resource Utilization 12 Months Following Initiation of Olanzapine/Samidorphan: Real-World Assessment of Patients with SchizophreniaAdvances in Therapy · 2026
2. Healthcare Resource Utilization 12 Months Following Initiation of Olanzapine/Samidorphan: Real-World Assessment of Patients with Bipolar I DisorderAdvances in Therapy · 2026
3. Abstract A054: Functional precision oncology in recurrent ependymoma: Multiplexed functional profiling reveals unexpected cytotoxic and anti-proliferative drug activityCancer Research · 2026
4. Depression severity and efficacy outcomes: post hoc analyses from a phase 3 trial of esmethadone for the adjunctive treatment of major depressive disorder with inadequate response to standard antidepressantsInternational Clinical Psychopharmacology · 2026
5. In Vitro, Ex Vivo and Clinical Trial of Brightening Serum Using a Novel Delivery System on Subjects With Moderate to Severe DyschromiaJournal of Cosmetic Dermatology · 2026
6. Assessing Night-to-Night Sleep Variability as a Hallmark of Chronic Insomnia Using Longitudinal, Contactless, Mobile Sleep Monitoring: Prospective Cohort StudyJMIR Formative Research · 2025
7. Efficacy and Tolerability of a Topical Peptide‐Hyaluronic Acid Lip Treatment Using a Novel Delivery System in Subjects With and Without Prior Lip AugmentationJournal of Cosmetic Dermatology · 2025
8. Multiple ischemic strokes in a patient treated with Lecanemab: a case reportNeurocase · 2025
9. Management of Parkinson’s disease psychosis: first-line antipsychotic selection and rationale for continuing, combining, or switchingExpert Opinion on Pharmacotherapy · 2025
10. Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of SchizophreniaNeuropsychiatric Disease and Treatment · 2025
11. Prescribing LAIs: from completing the first injection to going steadyCNS Spectrums · 2025
12. Understanding the delivery technology used in ADHD stimulant medications can help to individualize treatmentCNS Spectrums · 2025
13. What role did serious mental illness play in Jackson Pollock’s drip paintings? Abstract expressionism and possible links to serious mental illness and encrypted images (polloglyphs)CNS Spectrums · 2025
14. Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard AntidepressantsThe Journal of Clinical Psychiatry · 2024
15. Serdexmethylphenidate/dexmethylphenidate capsules for children and adolescents with attention-deficit/hyperactivity disorder (ADHD): a plain language summaryFuture Neurology · 2024
16. Comparison of Modified Beam F3 with Scalp Geometry-Based Parameter (SGP) for Locating the DLPFCBrain stimulation · 2023
17. Analysis of Growth Velocity in Children with Attention-Deficit/Hyperactivity Disorder Treated for up to 12 Months with Serdexmethylphenidate/DexmethylphenidateJournal of Child and Adolescent Psychopharmacology · 2023
18. Esmethadone-HCl (REL-1017): a promising rapid antidepressantEuropean Archives of Psychiatry and Clinical Neuroscience · 2023
19. Pedicle Screw-Associated Violation of the Adjacent Unfused Facet Joint: Clinical Outcomes and Fusion RatesGlobal Spine Journal · 2022
20. Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated SignalingInternational Journal of Molecular Sciences · 2022